Apyx Medical (APYX) Assets Average (2011 - 2026)

Apyx Medical has reported Assets Average for 16 years, with the latest figure at $64.9 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average rose 3.89% year-over-year to $64.9 million; the trailing twelve-month figure through Mar 2026 stood at $64.9 million (up 3.89% YoY), and the FY2025 full-year result was $65.8 million, down 8.61% from the prior year.
• Assets Average for Q1 2026 stood at $64.9 million, up from $62.1 million in the prior quarter.
• The five-year high for Assets Average was $75.0 million in Q1 2024, with the low at $53.5 million in Q4 2022.
• Historically, Assets Average has averaged $62.2 million across 5 years, with a median of $62.1 million in 2025.
• Annual changes were most pronounced in 2022 — Assets Average fell 21.57% — and 2024, when it jumped 38.13%.
• Apyx Medical's Assets Average stood at $53.5 million in 2022, then climbed by 29.56% to $69.3 million in 2023, then declined by 9.46% to $62.8 million in 2024, then decreased by 1.08% to $62.1 million in 2025, then advanced by 4.56% to $64.9 million in 2026.
• The last three Assets Average figures came in at $64.9 million (Q1 2026), $62.1 million (Q4 2025), and $57.8 million (Q3 2025), per Business Quant data.